Impact of fingolimod on brain volume measurements in relapsing-remitting patients with active disease at baseline: Results from the MS-MRIUS, a longitudinal, observational, multicenter real-world outcome study

Authors

• Robert Zivadinov
• Tanuja Chitnis
• Robert T. Naismith
• Enrique Alvarez
• Samuel F. Hunter
• SF Kinkel
• Stanley Cohan, Providence Multiple Sclerosis Center, USA.Follow

Document Type

Presentation

Publication Date

2017

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences